AJP - Heart and Circulatory Physiology, Vol 258, Issue 1 173-H178, Copyright © 1990 by American Physiological Society

ARTICLES

Augmented phosphoinositide metabolism in aortas from genetically hypertensive rats

M. B. Turla and R. C. Webb
Department of Physiology, University of Michigan Medical School, Ann Arbor 48109-0622.

Recent studies suggest that serotonergic receptor activation is coupled to phospholipase C-mediated phosphoinositide hydrolysis, which results in the release of intracellular second messengers. The purpose of this study was to determine whether altered phosphoinositide metabolism is the basis for augmented vascular responsiveness to serotonin in genetic hypertension. Thoracic aortic segments isolated from stroke-prone spontaneously hypertensive rats (SHRSP) and Wistar-Kyoto normotensive rats (WKY) were labeled with myo-[3H]inositol and stimulated with serotonin in the presence of LiCl. Accumulation of [3H]inositol phosphates was then quantitated by column chromatography. Basal inositol phosphate accumulation and basal incorporation of myo-[3H]inositol into aortic cell membranes from SHRSP was not significantly different from WKY values. At 2.6 x 10(-7) to 2.6 x 10(-4) M serotonin, phosphoinositide metabolism was significantly augmented in aortae from SHRSP compared with WKY. Depolarization (100 mM KCl) did not increase phosphoinositide hydrolysis above basal levels in SHRSP or WKY. 2-Nitro-4-carboxyphenyl-N,N-diphenyl carbamate (NCDC), an inhibitor of phospholipase C, prevented the serotonin-induced phosphoinositide metabolism. NCDC also partially inhibited phasic contractions (responses in calcium-free solution) to serotonin in aortas from SHRSP and WKY. In conclusion, abnormal phosphoinositide metabolism may be one mechanism responsible for the characteristic increase in vascular reactivity to serotonin in hypertension.

This article has been cited by other articles:

				J. A. Florian, A. Dorrance, R. C. Webb, and S. W. Watts Mineralocorticoids upregulate arterial contraction to epidermal growth factor Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2001; 281(3): R878 - R886. [Abstract] [Full Text] [PDF]

				C. M. McKune and S. W. Watts Characterization of the Serotonin Receptor Mediating Contraction in the Mouse Thoracic Aorta and Signal Pathway Coupling J. Pharmacol. Exp. Ther., April 1, 2001; 297(1): 88 - 95. [Abstract] [Full Text]

				W. Abebe and S. J. Mustafa A1 adenosine receptor-mediated Ins(1,4,5)P3 generation in allergic rabbit airway smooth muscle Am J Physiol Lung Cell Mol Physiol, November 1, 1998; 275(5): L990 - L997. [Abstract] [Full Text] [PDF]

				J. A. Florian and S. W. Watts Integration of Mitogen-Activated Protein Kinase Kinase Activation in Vascular 5-Hydroxytryptamine2A Receptor Signal Transduction J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 346 - 355. [Abstract] [Full Text]

				R. J. Baines, C. Brown, L. L. Ng, and M. R. Boarder Angiotensin II–Stimulated Phospholipase C Responses of Two Vascular Smooth Muscle–Derived Cell Lines: Role of Cyclic GMP Hypertension, November 1, 1996; 28(5): 772 - 778. [Abstract] [Full Text]